Tianda Pharmaceutical Co., Ltd. is committed to the research and development, production and sale of pharmaceuticals, biotechnology and health care products. Tianda Pharmaceutical is headquartered in Hong Kong, China, and has established marketing centers in Shenzhen and Sydney, and R&D centers and pharmaceutical bases in Zhuhai and Kunming. Both pharmaceutical bases have obtained the new GMP certification issued by China's China Food and Drug Administration, and the Zhuhai pharmaceutical base has also obtained GMP certification issued by the Australian Drug Administration. Tianda Pharmaceutical Co., Ltd. is listed on the main board of the Hong Kong Stock Exchange, stock code: 00455. Tianda Group Co., Ltd. is the controlling shareholder of Tianda Pharmaceutical and holds 55.56% of the shares.
No Data